Board of Trustees

WILLIAM WOOD ALLEN
Chief Executive Officer
WoodAllen Capital Management, LLC

PETER S. AMENTA, M.D., Ph.D.*
Interim Dean
UMDNJ-Robert Wood Johnson Medical School

SUBHA V. BARRY
Managing Director
Head of Global Diversity & Inclusion
Merrill Lynch & Company, Inc.

JOSEPH R. BERTINO, M.D.*
Interim Director
The Cancer Institute of New Jersey

THOMAS A. BRACKEN
President
TriState Capital Bank

ROBERT E. CAMPBELL
Chair, CINJ Advisory Council
Johnson & Johnson, Vice Chairman (Retired)

JEFFREY N. EDWARDS
Vice Chairman of the Executive Client Coverage Group
Merrill Lynch & Company, Inc.

AUDREY GOULD
Senior Vice President
The Gould Group of Wachovia Securities

WILLIAM N. HAIT, M.D., Ph.D.
Senior Vice President
Worldwide Head of Hematology/Oncology Research and Development
Johnson & Johnson Pharmaceutical Research and Development, LLC

DUNCAN L. MacMILLAN
Co-Founder
Bloomberg LP

PAUL MIGNON
President and Chief Operating Officer
Ventiv Pharma Teams
inVentiv Commercial Services

MICHELLE MORTON
President and Chief Executive Officer
Pacific American Securities, LLC

WILLIAM F. OWEN, Jr., M.D.*
President
University of Medicine and Dentistry of New Jersey

LESLIE LOGAN TAYLOR - Chair
Managing Partner
Matrix Development Group

JOHN R. WHITMAN
Managing Partner
Sycamore Management Corporation

MARK A. WOLTERS
President and Chief Executive Officer
Grand Bank

ARSHAD R. ZAKARIA
President and Chief Executive Officer
New Vernon Capital, LLC


*Ex-Officio